The expression of RIPK1 is elevated in psoriatic lesions compared with no lesion skin and atopic dermatitis, but downregulated RIPK1 enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) signaling in psoriasis (192). Here, RIPK1 is linked to atopic eczema.